Real-Time Continuous Glucose Monitoring in Adolescents and Young Adults With Type 2 Diabetes Can Improve Quality of Life

Objective: Real-time continuous glucose monitoring (CGM) is effective for diabetes management in cases of type 1 diabetes and adults with type 2 diabetes (T2D) but has not been assessed in adolescents and young adults (AYAs) with T2D. The objective of this pilot interventional study was to assess th...

Full description

Saved in:
Bibliographic Details
Published inJournal of diabetes science and technology Vol. 18; no. 4; pp. 911 - 919
Main Authors Chesser, Hannah, Srinivasan, Shylaja, Puckett, Cassidy, Gitelman, Stephen E., Wong, Jenise C.
Format Journal Article
LanguageEnglish
Published Los Angeles, CA SAGE Publications 01.07.2024
Subjects
Online AccessGet full text
ISSN1932-2968
1932-3107
DOI10.1177/19322968221139873

Cover

Loading…
Abstract Objective: Real-time continuous glucose monitoring (CGM) is effective for diabetes management in cases of type 1 diabetes and adults with type 2 diabetes (T2D) but has not been assessed in adolescents and young adults (AYAs) with T2D. The objective of this pilot interventional study was to assess the feasibility and acceptability of real-time CGM use in AYAs with T2D. Methods: Adolescents and young adults (13-21 years old) with T2D for six months or more and hemoglobin A1c (A1c) greater than 7%, on any Food and Drug Administration–approved treatment regimen, were included. After a blinded run-in period, participants were given access to a real-time CGM system for 12 weeks. The use and acceptability of the real-time CGM were evaluated by sensor usage, surveys, and focus group qualitative data. Results: Participants’ (n = 9) median age was 19.1 (interquartile range [IQR] 16.8-20.5) years, 78% were female, 100% were people of color, and 67% were publicly insured. Baseline A1c was 11.9% (standard deviation ±2.8%), with median diabetes duration of 2.5 (IQR 1.4-6) years, and 67% were using insulin. Seven participants completed the study and demonstrated statistically significant improvement in diabetes-related quality of life, with the mean Pediatric Quality of Life inventory (PedsQL) diabetes score increasing from 70 to 75 after using CGM (P = .026). Focus group results supported survey results that CGM use among AYAs with T2D is feasible, can improve quality of life, and has the potential to modify behavior. Conclusion: Real-time CGM is feasible and acceptable for AYAs with T2D and may improve the quality of life of patients with diabetes. Larger randomized controlled trials are needed to assess the effects on glycemic control and healthy lifestyle changes.
AbstractList Objective: Real-time continuous glucose monitoring (CGM) is effective for diabetes management in cases of type 1 diabetes and adults with type 2 diabetes (T2D) but has not been assessed in adolescents and young adults (AYAs) with T2D. The objective of this pilot interventional study was to assess the feasibility and acceptability of real-time CGM use in AYAs with T2D. Methods: Adolescents and young adults (13-21 years old) with T2D for six months or more and hemoglobin A1c (A1c) greater than 7%, on any Food and Drug Administration–approved treatment regimen, were included. After a blinded run-in period, participants were given access to a real-time CGM system for 12 weeks. The use and acceptability of the real-time CGM were evaluated by sensor usage, surveys, and focus group qualitative data. Results: Participants’ (n = 9) median age was 19.1 (interquartile range [IQR] 16.8-20.5) years, 78% were female, 100% were people of color, and 67% were publicly insured. Baseline A1c was 11.9% (standard deviation ±2.8%), with median diabetes duration of 2.5 (IQR 1.4-6) years, and 67% were using insulin. Seven participants completed the study and demonstrated statistically significant improvement in diabetes-related quality of life, with the mean Pediatric Quality of Life inventory (PedsQL) diabetes score increasing from 70 to 75 after using CGM (P = .026). Focus group results supported survey results that CGM use among AYAs with T2D is feasible, can improve quality of life, and has the potential to modify behavior. Conclusion: Real-time CGM is feasible and acceptable for AYAs with T2D and may improve the quality of life of patients with diabetes. Larger randomized controlled trials are needed to assess the effects on glycemic control and healthy lifestyle changes.
Real-time continuous glucose monitoring (CGM) is effective for diabetes management in cases of type 1 diabetes and adults with type 2 diabetes (T2D) but has not been assessed in adolescents and young adults (AYAs) with T2D. The objective of this pilot interventional study was to assess the feasibility and acceptability of real-time CGM use in AYAs with T2D.OBJECTIVEReal-time continuous glucose monitoring (CGM) is effective for diabetes management in cases of type 1 diabetes and adults with type 2 diabetes (T2D) but has not been assessed in adolescents and young adults (AYAs) with T2D. The objective of this pilot interventional study was to assess the feasibility and acceptability of real-time CGM use in AYAs with T2D.Adolescents and young adults (13-21 years old) with T2D for six months or more and hemoglobin A1c (A1c) greater than 7%, on any Food and Drug Administration-approved treatment regimen, were included. After a blinded run-in period, participants were given access to a real-time CGM system for 12 weeks. The use and acceptability of the real-time CGM were evaluated by sensor usage, surveys, and focus group qualitative data.METHODSAdolescents and young adults (13-21 years old) with T2D for six months or more and hemoglobin A1c (A1c) greater than 7%, on any Food and Drug Administration-approved treatment regimen, were included. After a blinded run-in period, participants were given access to a real-time CGM system for 12 weeks. The use and acceptability of the real-time CGM were evaluated by sensor usage, surveys, and focus group qualitative data.Participants' (n = 9) median age was 19.1 (interquartile range [IQR] 16.8-20.5) years, 78% were female, 100% were people of color, and 67% were publicly insured. Baseline A1c was 11.9% (standard deviation ±2.8%), with median diabetes duration of 2.5 (IQR 1.4-6) years, and 67% were using insulin. Seven participants completed the study and demonstrated statistically significant improvement in diabetes-related quality of life, with the mean Pediatric Quality of Life inventory (PedsQL) diabetes score increasing from 70 to 75 after using CGM (P = .026). Focus group results supported survey results that CGM use among AYAs with T2D is feasible, can improve quality of life, and has the potential to modify behavior.RESULTSParticipants' (n = 9) median age was 19.1 (interquartile range [IQR] 16.8-20.5) years, 78% were female, 100% were people of color, and 67% were publicly insured. Baseline A1c was 11.9% (standard deviation ±2.8%), with median diabetes duration of 2.5 (IQR 1.4-6) years, and 67% were using insulin. Seven participants completed the study and demonstrated statistically significant improvement in diabetes-related quality of life, with the mean Pediatric Quality of Life inventory (PedsQL) diabetes score increasing from 70 to 75 after using CGM (P = .026). Focus group results supported survey results that CGM use among AYAs with T2D is feasible, can improve quality of life, and has the potential to modify behavior.Real-time CGM is feasible and acceptable for AYAs with T2D and may improve the quality of life of patients with diabetes. Larger randomized controlled trials are needed to assess the effects on glycemic control and healthy lifestyle changes.CONCLUSIONReal-time CGM is feasible and acceptable for AYAs with T2D and may improve the quality of life of patients with diabetes. Larger randomized controlled trials are needed to assess the effects on glycemic control and healthy lifestyle changes.
Real-time continuous glucose monitoring (CGM) is effective for diabetes management in cases of type 1 diabetes and adults with type 2 diabetes (T2D) but has not been assessed in adolescents and young adults (AYAs) with T2D. The objective of this pilot interventional study was to assess the feasibility and acceptability of real-time CGM use in AYAs with T2D. Adolescents and young adults (13-21 years old) with T2D for six months or more and hemoglobin A1c (A1c) greater than 7%, on any Food and Drug Administration-approved treatment regimen, were included. After a blinded run-in period, participants were given access to a real-time CGM system for 12 weeks. The use and acceptability of the real-time CGM were evaluated by sensor usage, surveys, and focus group qualitative data. Participants' (n = 9) median age was 19.1 (interquartile range [IQR] 16.8-20.5) years, 78% were female, 100% were people of color, and 67% were publicly insured. Baseline A1c was 11.9% (standard deviation ±2.8%), with median diabetes duration of 2.5 (IQR 1.4-6) years, and 67% were using insulin. Seven participants completed the study and demonstrated statistically significant improvement in diabetes-related quality of life, with the mean Pediatric Quality of Life inventory (PedsQL) diabetes score increasing from 70 to 75 after using CGM ( = .026). Focus group results supported survey results that CGM use among AYAs with T2D is feasible, can improve quality of life, and has the potential to modify behavior. Real-time CGM is feasible and acceptable for AYAs with T2D and may improve the quality of life of patients with diabetes. Larger randomized controlled trials are needed to assess the effects on glycemic control and healthy lifestyle changes.
Author Puckett, Cassidy
Gitelman, Stephen E.
Wong, Jenise C.
Srinivasan, Shylaja
Chesser, Hannah
AuthorAffiliation 2 Department of Sociology, Emory University, Atlanta, GA, USA
1 Division of Endocrinology, Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA
AuthorAffiliation_xml – name: 2 Department of Sociology, Emory University, Atlanta, GA, USA
– name: 1 Division of Endocrinology, Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA
Author_xml – sequence: 1
  givenname: Hannah
  orcidid: 0000-0002-0724-4310
  surname: Chesser
  fullname: Chesser, Hannah
– sequence: 2
  givenname: Shylaja
  surname: Srinivasan
  fullname: Srinivasan, Shylaja
– sequence: 3
  givenname: Cassidy
  surname: Puckett
  fullname: Puckett, Cassidy
– sequence: 4
  givenname: Stephen E.
  surname: Gitelman
  fullname: Gitelman, Stephen E.
– sequence: 5
  givenname: Jenise C.
  orcidid: 0000-0003-0573-6650
  surname: Wong
  fullname: Wong, Jenise C.
  email: jenise.wong@ucsf.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36416098$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1v1DAQhi3Uin7AD-CCfOSSEn8ktk9otYVSaVEFWoQ4WU4y3rpy7CV2Kvbfk2i3VQGpJ1sz7_vO6JkzdBRiAITekPKCECHeE8UoVbWklBCmpGAv0OlcKxgpxdHhPwtO0FlKd2VZcSnES3TCak7qUslT9PsbGF-sXQ94GUN2YYxjwld-bGMC_CUGl-Pgwga7gBdd9JBaCDlhEzr8M45TY9GNfir8cPkWr3dbwBRfOtNAhoSXJuDrfjvEe8BfR-Nd3uFo8cpZeIWOrfEJXh_ec_T908f18nOxurm6Xi5WRcuZykVjjKyAMWaJVJY3VtREckOrqiKMl4IxUdGuBstrRaGR0rZGWFV1raklV4Sdow_73O3Y9NDN2w_G6-3gejPsdDRO_90J7lZv4r2ekJaCsjnh3SFhiL9GSFn3bqLgvQkwwdJUMMUZ4WU9Sd8-HfY45YH3JCB7QTvElAawjxJS6vmm-r-bTh7xj6d12WQX532df9Z5sXcmswF9F8chTKifMfwBgVGyGA
CitedBy_id crossref_primary_10_1177_26350106231205030
crossref_primary_10_1177_19322968231178284
crossref_primary_10_3390_children10030516
crossref_primary_10_1007_s40200_024_01403_9
crossref_primary_10_1111_1753_0407_13454
crossref_primary_10_1111_dom_15328
crossref_primary_10_1186_s13690_024_01459_2
crossref_primary_10_1038_s41574_024_00973_1
crossref_primary_10_1089_dia_2023_0268
crossref_primary_10_2337_dc25_S014
crossref_primary_10_1089_dia_2024_0539
crossref_primary_10_2337_dc25_S007
crossref_primary_10_1016_j_ecl_2025_02_018
crossref_primary_10_1155_2023_1979635
crossref_primary_10_1007_s00125_024_06203_7
Cites_doi 10.2337/dc18-1581
10.1093/jpepsy/jsx146
10.2337/dci19-0028
10.1111/ijpo.12846
10.1089/dia.2018.0177
10.3945/jn.116.246058
10.2337/dc21-S013
10.1001/archinternmed.2009.193
10.1111/nyas.14270
10.1056/NEJMoa2100165
10.2337/dc21-S007
10.1089/15209150050214131
10.1210/jc.2016-2534
10.2337/dc16-1066
10.1016/S0140-6736(17)31371-5
10.1016/j.jbi.2008.08.010
10.1556/2006.2020.00053
10.1210/clinem/dgab896
10.1001/jama.2021.11165
10.2337/dc11-1438
10.1177/1932296821997851
10.1007/s11892-017-0905-0
10.1016/j.diabres.2008.06.015
10.1210/jc.2014-3612
10.1016/j.dsx.2020.07.051
10.1016/j.dsx.2019.07.054
10.7326/M16-2855
10.1089/dia.2019.0303
10.2337/dc09-1502
10.3390/ijerph17228479
10.1016/S0140-6736(17)32461-3
10.1001/jama.2021.6530
10.1210/jc.2010-2756
10.1093/jpepsy/27.1.47
10.1057/978-1-137-58614-8
10.1093/jamia/ocx025
10.4158/EP161392.CS
10.7326/0003-4819-157-5-201209040-00508
10.2337/dc09-0108
10.1177/1357633X20972911
10.1123/pes.9.4.342
10.2337/dc10-1989
10.1186/s13098-020-00584-6
10.3390/nu12061583
10.1177/160940690900800301
10.2337/dc17-1600
10.1111/dme.13841
10.1136/bmj.d3805
10.1056/NEJMoa052187
10.1016/j.jdiacomp.2016.10.007
10.2196/jmir.6382
10.4103/jpbs.JPBS_7_20
ContentType Journal Article
Copyright 2022 Diabetes Technology Society
2022 Diabetes Technology Society 2022 Diabetes Technology Society
Copyright_xml – notice: 2022 Diabetes Technology Society
– notice: 2022 Diabetes Technology Society 2022 Diabetes Technology Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1177/19322968221139873
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1932-3107
EndPage 919
ExternalDocumentID PMC11307231
36416098
10_1177_19322968221139873
10.1177_19322968221139873
Genre Journal Article
GrantInformation_xml – fundername: NIDDK NIH HHS
  grantid: K23 DK120932
– fundername: NIDDK NIH HHS
  grantid: T32 DK007161
GroupedDBID ---
-TM
0R~
53G
54M
AABMB
AACMV
AACTG
AADCB
AADUE
AAEWN
AAGLT
AAGMC
AAJPV
AAKGS
AANEX
AAQXI
AARDL
AARIX
AATAA
AATBZ
AAUAS
ABAWP
ABCCA
ABCJG
ABEIX
ABFWQ
ABIDT
ABJIS
ABJNI
ABJZC
ABKRH
ABLUO
ABPNF
ABQXT
ABRHV
ABUJY
ABVFX
ACARO
ACDSZ
ACDXX
ACFEJ
ACGFO
ACGFS
ACGZU
ACJER
ACJTF
ACLFY
ACLZU
ACOFE
ACOXC
ACROE
ACSIQ
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADDVE
ADEBD
ADNON
ADRRZ
ADVBO
ADZZY
AECGH
AEDTQ
AEKYL
AEPTA
AEQLS
AERKM
AESZF
AEUHG
AEWDL
AEWHI
AEXNY
AFEET
AFKRG
AFMOU
AFQAA
AFUIA
AGHKR
AGKLV
AGNHF
AGPXR
AGWFA
AHDMH
AJUZI
AJXAJ
ALJHS
ALKWR
ALMA_UNASSIGNED_HOLDINGS
AMCVQ
ANDLU
AOIJS
ARTOV
AUTPY
AYAKG
B8M
BAWUL
BBRGL
BDDNI
BKIIM
BKSCU
BPACV
BSEHC
BWJAD
C45
CDWPY
CFDXU
DC-
DC.
DIK
DOPDO
DV7
E3Z
EBS
EJD
EMOBN
F5P
FHBDP
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
GX1
H13
HYE
J8X
K.F
O9-
OK1
OVD
P2P
P6G
ROL
RPM
SASJQ
SAUOL
SCNPE
SFC
SFH
SHG
SJN
SPQ
SPV
TEORI
TR2
ZONMY
ZPPRI
ZRKOI
ZSSAH
AAYXX
AJGYC
CITATION
AAPII
AJVBE
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
AJHME
ID FETCH-LOGICAL-c439t-baa85e333f189f4bf76184a25551340733752d6ef4692eb88fca7f95dca684913
ISSN 1932-2968
IngestDate Thu Aug 21 18:31:52 EDT 2025
Fri Jul 11 12:08:41 EDT 2025
Mon Jul 21 06:01:12 EDT 2025
Thu Apr 24 22:55:24 EDT 2025
Tue Jul 01 00:49:40 EDT 2025
Tue Jun 17 22:31:30 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords lifestyle factors
sensors
type 2 diabetes
continuous glucose monitoring
adolescents
pediatrics
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c439t-baa85e333f189f4bf76184a25551340733752d6ef4692eb88fca7f95dca684913
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-0573-6650
0000-0002-0724-4310
OpenAccessLink https://escholarship.org/content/qt7w308878/qt7w308878.pdf
PMID 36416098
PQID 2739431406
PQPubID 23479
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11307231
proquest_miscellaneous_2739431406
pubmed_primary_36416098
crossref_primary_10_1177_19322968221139873
crossref_citationtrail_10_1177_19322968221139873
sage_journals_10_1177_19322968221139873
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-07-01
PublicationDateYYYYMMDD 2024-07-01
PublicationDate_xml – month: 07
  year: 2024
  text: 2024-07-01
  day: 01
PublicationDecade 2020
PublicationPlace Los Angeles, CA
PublicationPlace_xml – name: Los Angeles, CA
– name: United States
– name: Sage CA: Los Angeles, CA
PublicationTitle Journal of diabetes science and technology
PublicationTitleAlternate J Diabetes Sci Technol
PublicationYear 2024
Publisher SAGE Publications
Publisher_xml – name: SAGE Publications
References Kowalski, Crocker, Kowalski 1997; 9
Bergenstal, Beck, Close 2018; 41
Alessi, de Oliveira, Franco 2020; 12
Pickup, Freeman, Sutton 2011; 343
Heary, Hennessy 2002; 27
Flaudias, Iceta, Zerhouni 2020; 9
Lawrence, Divers, Isom 2021; 326
Danne, Nimri, Battelino 2017; 40
Harris, Taylor, Thielke, Payne, Gonzalez, Conde 2009; 42
Vigersky, Fonda, Chellappa, Walker, Ehrhardt 2012; 35
Onwuegbuzie, Dickinson, Leech, Zoran 2009; 8
McGavock, Wicklow, Dart 2017 1829; 390
Varni, Delamater, Hood 2019; 36
Dhaliwal, Pereira, Diaz-Thomas, Powe, Yanes Cardozo, Joseph 2022; 107
Yeh, Brown, Maruthur 2012; 157
Peters, Ahmann, Battelino 2016; 101
Azhar, Gillani, Mohiuddin, Majeed 2020; 12
Shapiro, Vesco, Weil, Evans, Hood, Weissberg-Benchell 2018; 43
Battelino, Danne, Bergenstal 2019; 42
Klonoff, Buckingham, Christiansen 2011; 96
Langendam, Luijf, Hooft, Devries, Mudde, Scholten 2012; 1
Nearchou, Flinn, Niland, Subramaniam, Hennessy 2020; 17
Nadeau, Anderson, Berg 2016; 39
Pintus, Ng 2019; 13
Burkart, Parker, Weaver 2022; 17
2020; 44
Karter, Parker, Moffet, Gilliam, Dlott 2021; 325
Nathan, Zinman, Cleary 2009; 169
Beck, Hirsch, Laffel 2009; 32
2010; 33
Alshareef, Al Zahrani, Alzahrani, Ghandoura 2020; 14
2021; 44
Haynes, Kompala, Neinstein, Rosenthal, Crossen 2021; 15
Thornton, Kumanyika, Gregg 2020; 1461
Battelino, Phillip, Bratina, Nimri, Oskarsson, Bolinder 2011; 34
Beck, Riddlesworth, Ruedy 2017; 167
Park, Le 2018; 20
Fonseca, Grunberger, Anhalt 2016; 22
Thompson, Midthune, Kahle, Dodd 2017; 147
Vigersky, Shrivastav 2017; 31
Nathan, Cleary, Backlund 2005; 353
Alvarado, Kum, Gonzalez Coronado, Foster, Ortega, Lawley 2017; 19
Chan, Pyle, Newnes, Nadeau, Zeitler, Kelsey 2015; 100
Chan 2017; 17
Viner, White, Christie 2017; 389
Ammar, Brach, Trabelsi 2020; 12
Haynes, Marcin, Dayal, Tancredi, Crossen 2020; 0
Boland, Tamborlane 2000; 2
Heitkemper, Mamykina, Travers, Smaldone 2017; 24
Anderson, Gavin, Kruger 2020; 22
Yoo, An, Park 2008; 82
Bjornstad, Drews 2021; 385
bibr9-19322968221139873
bibr21-19322968221139873
bibr47-19322968221139873
bibr19-19322968221139873
bibr14-19322968221139873
bibr27-19322968221139873
bibr41-19322968221139873
bibr54-19322968221139873
bibr34-19322968221139873
Langendam M (bibr11-19322968221139873) 2012; 1
bibr13-19322968221139873
bibr33-19322968221139873
bibr39-19322968221139873
bibr26-19322968221139873
bibr46-19322968221139873
bibr3-19322968221139873
bibr40-19322968221139873
bibr20-19322968221139873
bibr15-19322968221139873
bibr50-19322968221139873
bibr25-19322968221139873
bibr5-19322968221139873
bibr4-19322968221139873
bibr45-19322968221139873
bibr35-19322968221139873
bibr55-19322968221139873
bibr44-19322968221139873
bibr6-19322968221139873
bibr37-19322968221139873
bibr1-19322968221139873
bibr17-19322968221139873
bibr31-19322968221139873
bibr24-19322968221139873
bibr51-19322968221139873
bibr49-19322968221139873
bibr23-19322968221139873
bibr16-19322968221139873
bibr29-19322968221139873
bibr36-19322968221139873
bibr30-19322968221139873
bibr43-19322968221139873
bibr10-19322968221139873
bibr28-19322968221139873
bibr18-19322968221139873
bibr53-19322968221139873
bibr2-19322968221139873
bibr12-19322968221139873
bibr7-19322968221139873
bibr42-19322968221139873
bibr52-19322968221139873
bibr32-19322968221139873
bibr22-19322968221139873
bibr8-19322968221139873
bibr38-19322968221139873
bibr48-19322968221139873
References_xml – volume: 36
  start-page: 465
  issue: 4
  year: 2019
  end-page: 472
  article-title: Pediatric Quality of Life Inventory (PedsQL) 3.2 Diabetes Module for youth with Type 2 diabetes: reliability and validity
  publication-title: Diabet Med
– volume: 167
  start-page: 365
  issue: 6
  year: 2017
  end-page: 374
  article-title: Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections
  publication-title: Ann Intern Med
– volume: 17
  start-page: e12846
  issue: 1
  year: 2022
  article-title: Impact of the COVID-19 pandemic on elementary schoolers’ physical activity, sleep, screen time and diet: a quasi-experimental interrupted time series study
  publication-title: Pediatr Obes
– volume: 343
  start-page: d3805
  year: 2011
  article-title: Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data
  publication-title: BMJ
– volume: 107
  start-page: 1205
  issue: 5
  year: 2022
  end-page: 1215
  article-title: Eradicating racism: an endocrine society policy perspective
  publication-title: J Clin Endocrinol Metab
– volume: 39
  start-page: 1635
  issue: 9
  year: 2016
  end-page: 1642
  article-title: Youth-onset type 2 diabetes consensus report: current status, challenges, and priorities
  publication-title: Diabetes Care
– volume: 100
  start-page: 902
  issue: 3
  year: 2015
  end-page: 910
  article-title: Continuous glucose monitoring and its relationship to hemoglobin A1c and oral glucose tolerance testing in obese and prediabetic youth
  publication-title: J Clin Endocrinol Metab
– volume: 17
  start-page: 66
  issue: 9
  year: 2017
  article-title: Use of continuous glucose monitoring in youth-onset type 2 diabetes
  publication-title: Curr Diab Rep
– volume: 34
  start-page: 795
  issue: 4
  year: 2011
  end-page: 800
  article-title: Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes
  publication-title: Diabetes Care
– volume: 42
  start-page: 377
  issue: 2
  year: 2009
  end-page: 381
  article-title: Research Electronic Data Capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support
  publication-title: J Biomed Inform
– volume: 101
  start-page: 3922
  issue: 11
  year: 2016
  end-page: 3937
  article-title: Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an Endocrine Society Clinical Practice Guideline
  publication-title: J Clin Endocrinol Metab
– volume: 35
  start-page: 32
  issue: 1
  year: 2012
  end-page: 38
  article-title: Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes
  publication-title: Diabetes Care
– volume: 40
  start-page: 1631
  issue: 12
  year: 2017
  end-page: 1640
  article-title: International consensus on use of continuous glucose monitoring
  publication-title: Diabetes Care
– volume: 82
  start-page: 73
  issue: 1
  year: 2008
  end-page: 79
  article-title: Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes
  publication-title: Diabetes Res Clin Pract
– volume: 385
  start-page: 416
  issue: 5
  year: 2021
  end-page: 426
  article-title: Long-term complications in youth-onset type 2 diabetes
  publication-title: N Engl J Med
– volume: 325
  start-page: 2273
  issue: 22
  year: 2021
  end-page: 2284
  article-title: Association of real-time continuous glucose monitoring with glycemic control and acute metabolic events among patients with insulin-treated diabetes
  publication-title: JAMA
– volume: 8
  start-page: 1
  issue: 3
  year: 2009
  end-page: 21
  article-title: A qualitative framework for collecting and analyzing data in focus group research
  publication-title: Int J Qual Methods
– volume: 1461
  start-page: 5
  issue: 1
  year: 2020
  end-page: 24
  article-title: New research directions on disparities in obesity and type 2 diabetes
  publication-title: Ann N Y Acad Sci
– volume: 32
  start-page: 1378
  issue: 8
  year: 2009
  end-page: 1383
  article-title: The effect of continuous glucose monitoring in well-controlled type 1 diabetes
  publication-title: Diabetes Care
– volume: 353
  start-page: 2643
  issue: 25
  year: 2005
  end-page: 2653
  article-title: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
  publication-title: N Engl J Med
– volume: 31
  start-page: 280
  issue: 1
  year: 2017
  end-page: 287
  article-title: Role of continuous glucose monitoring for type 2 in diabetes management and research
  publication-title: J Diabetes Complications
– volume: 96
  start-page: 2968
  issue: 10
  year: 2011
  end-page: 2979
  article-title: Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline
  publication-title: J Clin Endocrinol Metab
– volume: 12
  start-page: 76
  year: 2020
  article-title: Mental health in the era of COVID-19: prevalence of psychiatric disorders in a cohort of patients with type 1 and type 2 diabetes during the social distancing
  publication-title: Diabetol Metab Syndr
– volume: 24
  start-page: 1024
  issue: 5
  year: 2017
  end-page: 1035
  article-title: Do health information technology self-management interventions improve glycemic control in medically underserved adults with diabetes? a systematic review and meta-analysis
  publication-title: J Am Med Inform Assoc
– volume: 326
  start-page: 717
  issue: 8
  year: 2021
  end-page: 727
  article-title: Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017
  publication-title: JAMA
– volume: 9
  start-page: 342
  issue: 4
  year: 1997
  end-page: 352
  article-title: Convergent validity of the physical activity questionnaire for adolescents
  publication-title: Pediatr Exerc Sci
– volume: 14
  start-page: 1583
  issue: 5
  year: 2020
  end-page: 1587
  article-title: Impact of the COVID-19 lockdown on diabetes patients in Jeddah, Saudi Arabia
  publication-title: Diabetes Metab Syndr
– volume: 19
  start-page: e28
  issue: 2
  year: 2017
  article-title: Barriers to remote health interventions for type 2 diabetes: a systematic review and proposed classification scheme
  publication-title: J Med Internet Res
– volume: 44
  start-page: S180
  year: 2021
  end-page: S199
  article-title: 13. Children and adolescents: standards of medical care in diabetes—2021
  publication-title: Diabetes Care
– volume: 13
  start-page: 2923
  issue: 5
  year: 2019
  end-page: 2926
  article-title: Freestyle libre flash glucose monitoring improves patient quality of life measures in children with Type 1 diabetes mellitus (T1DM) with appropriate provision of education and support by healthcare professionals
  publication-title: Diabetes Metab Syndr
– volume: 22
  start-page: 169
  issue: 3
  year: 2020
  end-page: 173
  article-title: Current eligibility requirements for CGM coverage are harmful, costly, and unjustified
  publication-title: Diabetes Technol Ther
– volume: 33
  start-page: 17
  issue: 1
  year: 2010
  end-page: 22
  article-title: Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial
  publication-title: Diabetes Care
– volume: 12
  start-page: E1583
  issue: 6
  year: 2020
  article-title: Effects of COVID-19 home confinement on eating behaviour and physical activity: results of the ECLB-COVID19 international online survey
  publication-title: Nutrients
– volume: 157
  start-page: 336
  issue: 5
  year: 2012
  end-page: 347
  article-title: Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis
  publication-title: Ann Intern Med
– volume: 15
  start-page: 986
  issue: 5
  year: 2021
  end-page: 992
  article-title: Disparities in telemedicine use for subspecialty diabetes care during COVID-19 shelter-in-place orders
  publication-title: J Diabetes Sci Technol
– volume: 9
  start-page: 826
  issue: 3
  year: 2020
  end-page: 835
  article-title: COVID-19 pandemic lockdown and problematic eating behaviors in a student population
  publication-title: J Behav Addict
– volume: 12
  start-page: 102
  issue: 2
  year: 2020
  end-page: 111
  article-title: A systematic review on clinical implication of continuous glucose monitoring in diabetes management
  publication-title: J Pharm Bioallied Sci
– volume: 0
  issue: 0
  year: 2020
  article-title: Impact of telemedicine on visit attendance for paediatric patients receiving endocrinology specialty care
  publication-title: J Telemed Telecare
– volume: 44
  start-page: S85
  year: 2020
  end-page: 99
  article-title: 7. Diabetes technology: standards of medical care in diabetes—2021
  publication-title: Diabetes Care
– volume: 41
  start-page: 2275
  issue: 11
  year: 2018
  end-page: 2280
  article-title: Glucose management indicator (GMI): a new term for estimating A1c from continuous glucose monitoring
  publication-title: Diabetes Care
– volume: 389
  start-page: 2252
  issue: 10085
  year: 2017
  end-page: 2260
  article-title: Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden
  publication-title: The Lancet
– volume: 1
  start-page: CD008101
  year: 2012
  article-title: Continuous glucose monitoring systems for type 1 diabetes mellitus
  publication-title: Cochrane Database Syst Rev
– volume: 17
  start-page: 8479
  issue: 22
  year: 2020
  article-title: Exploring the impact of COVID-19 on mental health outcomes in children and adolescents: a systematic review
  publication-title: Int J Environ Res Public Health
– volume: 169
  start-page: 1307
  issue: 14
  year: 2009
  end-page: 1316
  article-title: Modern-day clinical course of type 1 diabetes mellitus after 30 years’ duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005)
  publication-title: Arch Intern Med
– volume: 2
  start-page: S53
  year: 2000
  end-page: S59
  article-title: Continuous glucose monitoring in youth with type 2 diabetes: overcoming barriers to successful treatment
  publication-title: Diabetes Technol Ther
– volume: 27
  start-page: 47
  issue: 1
  year: 2002
  end-page: 57
  article-title: The use of focus group interviews in pediatric healthcare research
  publication-title: J Pediatr Psychol
– volume: 22
  start-page: 1008
  issue: 8
  year: 2016
  end-page: 1021
  article-title: Continuous glucose monitoring: a consensus conference of the American Association of Clinical Endocrinologists and American College of Endocrinology
  publication-title: Endocr Pract
– volume: 147
  start-page: 1226
  issue: 6
  year: 2017
  end-page: 1233
  article-title: Development and evaluation of the National Cancer Institute’s dietary screener questionnaire scoring algorithms
  publication-title: J Nutr
– volume: 43
  start-page: 561
  issue: 5
  year: 2018
  end-page: 571
  article-title: Psychometric properties of the problem areas in diabetes: teen and parent of teen versions
  publication-title: J Pediatr Psychol
– volume: 390
  issue: 10105
  year: 2017 1829
  article-title: Type 2 diabetes in youth is a disease of poverty
  publication-title: The Lancet
– volume: 42
  start-page: 1593
  issue: 8
  year: 2019
  end-page: 1603
  article-title: Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range
  publication-title: Diabetes Care
– volume: 20
  start-page: 613
  issue: 9
  year: 2018
  end-page: 621
  article-title: The effectiveness of continuous glucose monitoring in patients with type 2 diabetes: a systematic review of literature and meta-analysis
  publication-title: Diabetes Technol Ther
– volume: 1
  start-page: CD008101
  year: 2012
  ident: bibr11-19322968221139873
  publication-title: Cochrane Database Syst Rev
– ident: bibr30-19322968221139873
  doi: 10.2337/dc18-1581
– ident: bibr33-19322968221139873
  doi: 10.1093/jpepsy/jsx146
– ident: bibr29-19322968221139873
  doi: 10.2337/dci19-0028
– ident: bibr42-19322968221139873
  doi: 10.1111/ijpo.12846
– ident: bibr15-19322968221139873
  doi: 10.1089/dia.2018.0177
– ident: bibr32-19322968221139873
  doi: 10.3945/jn.116.246058
– ident: bibr27-19322968221139873
  doi: 10.2337/dc21-S013
– ident: bibr6-19322968221139873
  doi: 10.1001/archinternmed.2009.193
– ident: bibr50-19322968221139873
  doi: 10.1111/nyas.14270
– ident: bibr7-19322968221139873
  doi: 10.1056/NEJMoa2100165
– ident: bibr24-19322968221139873
  doi: 10.2337/dc21-S007
– ident: bibr25-19322968221139873
  doi: 10.1089/15209150050214131
– ident: bibr22-19322968221139873
  doi: 10.1210/jc.2016-2534
– ident: bibr3-19322968221139873
  doi: 10.2337/dc16-1066
– ident: bibr2-19322968221139873
  doi: 10.1016/S0140-6736(17)31371-5
– ident: bibr28-19322968221139873
  doi: 10.1016/j.jbi.2008.08.010
– ident: bibr43-19322968221139873
  doi: 10.1556/2006.2020.00053
– ident: bibr51-19322968221139873
– ident: bibr53-19322968221139873
  doi: 10.1210/clinem/dgab896
– ident: bibr1-19322968221139873
  doi: 10.1001/jama.2021.11165
– ident: bibr17-19322968221139873
  doi: 10.2337/dc11-1438
– ident: bibr48-19322968221139873
  doi: 10.1177/1932296821997851
– ident: bibr4-19322968221139873
  doi: 10.1007/s11892-017-0905-0
– ident: bibr16-19322968221139873
  doi: 10.1016/j.diabres.2008.06.015
– ident: bibr26-19322968221139873
  doi: 10.1210/jc.2014-3612
– ident: bibr38-19322968221139873
  doi: 10.1016/j.dsx.2020.07.051
– ident: bibr41-19322968221139873
  doi: 10.1016/j.dsx.2019.07.054
– ident: bibr18-19322968221139873
  doi: 10.7326/M16-2855
– ident: bibr54-19322968221139873
  doi: 10.1089/dia.2019.0303
– ident: bibr9-19322968221139873
  doi: 10.2337/dc09-1502
– ident: bibr40-19322968221139873
  doi: 10.3390/ijerph17228479
– ident: bibr52-19322968221139873
  doi: 10.1016/S0140-6736(17)32461-3
– ident: bibr19-19322968221139873
  doi: 10.1001/jama.2021.6530
– ident: bibr20-19322968221139873
  doi: 10.1210/jc.2010-2756
– ident: bibr36-19322968221139873
  doi: 10.1093/jpepsy/27.1.47
– ident: bibr35-19322968221139873
  doi: 10.1057/978-1-137-58614-8
– ident: bibr46-19322968221139873
  doi: 10.1093/jamia/ocx025
– ident: bibr21-19322968221139873
  doi: 10.4158/EP161392.CS
– ident: bibr13-19322968221139873
  doi: 10.7326/0003-4819-157-5-201209040-00508
– ident: bibr8-19322968221139873
  doi: 10.2337/dc09-0108
– ident: bibr47-19322968221139873
  doi: 10.1177/1357633X20972911
– ident: bibr31-19322968221139873
  doi: 10.1123/pes.9.4.342
– ident: bibr10-19322968221139873
  doi: 10.2337/dc10-1989
– ident: bibr39-19322968221139873
  doi: 10.1186/s13098-020-00584-6
– ident: bibr44-19322968221139873
  doi: 10.3390/nu12061583
– ident: bibr37-19322968221139873
  doi: 10.1177/160940690900800301
– ident: bibr23-19322968221139873
  doi: 10.2337/dc17-1600
– ident: bibr49-19322968221139873
– ident: bibr34-19322968221139873
  doi: 10.1111/dme.13841
– ident: bibr12-19322968221139873
  doi: 10.1136/bmj.d3805
– ident: bibr5-19322968221139873
  doi: 10.1056/NEJMoa052187
– ident: bibr14-19322968221139873
  doi: 10.1016/j.jdiacomp.2016.10.007
– ident: bibr45-19322968221139873
  doi: 10.2196/jmir.6382
– ident: bibr55-19322968221139873
  doi: 10.4103/jpbs.JPBS_7_20
SSID ssj0054877
Score 2.4709504
Snippet Objective: Real-time continuous glucose monitoring (CGM) is effective for diabetes management in cases of type 1 diabetes and adults with type 2 diabetes (T2D)...
Real-time continuous glucose monitoring (CGM) is effective for diabetes management in cases of type 1 diabetes and adults with type 2 diabetes (T2D) but has...
SourceID pubmedcentral
proquest
pubmed
crossref
sage
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 911
SubjectTerms Adolescent
Blood Glucose - analysis
Blood Glucose Self-Monitoring
Continuous Glucose Monitoring
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - psychology
Feasibility Studies
Female
Glycated Hemoglobin - analysis
Humans
Hypoglycemic Agents - administration & dosage
Hypoglycemic Agents - therapeutic use
Male
Original
Pilot Projects
Quality of Life
Young Adult
Title Real-Time Continuous Glucose Monitoring in Adolescents and Young Adults With Type 2 Diabetes Can Improve Quality of Life
URI https://journals.sagepub.com/doi/full/10.1177/19322968221139873
https://www.ncbi.nlm.nih.gov/pubmed/36416098
https://www.proquest.com/docview/2739431406
https://pubmed.ncbi.nlm.nih.gov/PMC11307231
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ta9swEBZZB2Nfyt7nvaHBYLDiYlvyiz6WrF0ZaTc2B_LNyLZMMoJbWmds_SP9u7uTZDvG2-j2xQTFloXv0enu9NyJkDdMlbH0CuGyCiY5Z6x0hRfmbsgD6ZdcqlCHBk5Oo-M5_7gIF5PJ9RZradPk-8XVb_NK_keq0AZyxSzZf5Bs1yk0wG-QL1xBwnC9kYy_gJXnYhIHJu41q3qDfNYPloRuZuuFzVk56Cs36f0CPcuhdbNukALbLPdSE4x93wZjpzDzTchB7ZlKG3ozfraqhuyh3qLt4rhtrpBmZ45i99OlrleuFz1Z131A-ivuJn2XlzYmu_y5lt-6VeMzEkAaS1KBiVz2NFSwmtdtINeQ1mx-hY1mBLxjvrYKGOxJNxDmqJ191bcxezruWGv3IQmtgoVR3uOlQW9OY1_YfQCOLxOJOUZlWIb79FN2NJ_NsvRwkd4itwPwP_w2DGSWePTyYkNXMIO12-VYyWv0gqHBM_JixmTcLUahNnLSe2TXypIeGKjdJxNVPyB3Tiz_4iH50SGO9oijFnG0Rxxd1XQLcRSAQDXiqEEcRcRRRBwNaIs4CoijFnHUIo6eVRQR94jMjw7T6bFrz-5wCzBxGzeXMgkVY6ACElHxvIrxZCEJDmzoM44nhcZhUEaq4pEIVJ4kVSHjSoRlIaOEC589Jjv1Wa2eEgpKhsdlEquAg7kP3cX4iMgr0C5lrjyHeO0Hzgpb2B7PV1lnvq1lP5KJQ951j5ybqi5_u_l1K7UMdC9uqMlawefNwPQXYICDTeyQJ0aKXXcsAlfHE4lDkoF8uxuwrvvwn3q11PXd4b1eDH6XQ94iFDKrcS7_PMRnNxjic3K3n3AvyE5zsVEvwaBu8lca3L8AJmrI9w
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Real-Time+Continuous+Glucose+Monitoring+in+Adolescents+and+Young+Adults+With+Type+2+Diabetes+Can+Improve+Quality+of+Life&rft.jtitle=Journal+of+diabetes+science+and+technology&rft.au=Chesser%2C+Hannah&rft.au=Srinivasan%2C+Shylaja&rft.au=Puckett%2C+Cassidy&rft.au=Gitelman%2C+Stephen+E&rft.date=2024-07-01&rft.issn=1932-2968&rft.eissn=1932-3107&rft.volume=18&rft.issue=4&rft.spage=911&rft_id=info:doi/10.1177%2F19322968221139873&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-2968&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-2968&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-2968&client=summon